Overall, ICA exerted its primary effects on CRC cells by modulating the interaction between HSP90 and TXNDC9, consequently reducing TXNDC9 protein levels, promoting autophagic cell death, enhancing apoptosis, and ultimately achieving its antitumor effects. This evidence concerns the gene HSP90AA1 and colorectal carcinoma.